Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5024)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 28, 2023 (publication date) through Jun 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Halkjær SI, Lo B, Cold F, Højer Christensen A, Holster S, König J, Brummer RJ, Aroniadis OC, Lahtinen P, Holvoet T, Gluud LL, Petersen AM. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis. World J Gastroenterol 2023; 29(20): 3185-3202 [PMID: 37346153 DOI: 10.3748/wjg.v29.i20.3185] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i20/3185.htm |
| Number | Citing Articles |
| 1 |
Isreal Ayobami Onifade, Oluwatomiwa Jubilee Sunbare-Funto, Chinedu Endurance Mbah, Oluwatosin Akinola Ajibade, Olubukola Monisola Oyawoye, Abdullahi Tunde Aborode, Seto Charles Ogunleye, Abdullahi Jamiu, Basit Bolarinwa, Mosope F. Abanikannda, Zainab Tiamiyu, Abidemi Ruth Idowu, Oluwatobiloba Ige, Opara Julia Kelechi, Jeremiah I. Abok, Eniola A. Lawal, Ibude Jane Aruorivwooghene, Adekunle Fatai Adeoye, Olowo Roqeebah, Emmanuel Akinloye Ojewole, Ridwan Olamilekan Adesola. Faecal microbial transplant. Advances in Biomarker Sciences and Technology 2024; 6: 20 doi: 10.1016/j.abst.2024.02.001
|
| 2 |
Yunyao Qu, Si Hong Park, David C. Dallas. Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study. Nutrients 2023; 15(19): 4174 doi: 10.3390/nu15194174
|
| 3 |
Jessica R. Allegretti, Sahil Khanna, Benjamin H. Mullish, Paul Feuerstadt. The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond. Gastroenterology 2024; doi: 10.1053/j.gastro.2024.05.004
|
| 4 |
B.H. Mullish, B. Merrick, M.N. Quraishi, A. Bak, C.A. Green, D.J. Moore, R.J. Porter, N.T. Elumogo, J.P. Segal, N. Sharma, B. Marsh, G. Kontkowski, S.E. Manzoor, A.L. Hart, C. Settle, J.J. Keller, P. Hawkey, T.H. Iqbal, S.D. Goldenberg, H.R.T. Williams. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Journal of Hospital Infection 2024; 148: 189 doi: 10.1016/j.jhin.2024.03.001
|
| 5 |
Cong Dai, Yu-Hong Huang, Min Jiang. Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives. World Journal of Gastroenterology 2024; 30(16): 2179-2183 doi: 10.3748/wjg.v30.i16.2179
|
| 6 |
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Increasing the transplant dose and repeating faecal microbiota transplantation results in the responses of male patients with IBS reaching those of females. Scandinavian Journal of Gastroenterology 2024; 59(4): 391 doi: 10.1080/00365521.2023.2292479
|
| 7 |
Yuxuan Chen, Shuyan Feng, Ying Li, Chi Zhang, Guanqun Chao, Shuo Zhang. Gut microbiota and intestinal immunity—A crosstalk in irritable bowel syndrome. Immunology 2024; 172(1): 1 doi: 10.1111/imm.13749
|
| 8 |
Benjamin H Mullish, Blair Merrick, Mohammed Nabil Quraishi, Aggie Bak, Christopher A Green, David J Moore, Robert J Porter, Ngozi T Elumogo, Jonathan P Segal, Naveen Sharma, Belinda Marsh, Graziella Kontkowski, Susan E Manzoor, Ailsa L Hart, Christopher Settle, Josbert J Keller, Peter Hawkey, Tariq H Iqbal, Simon D Goldenberg, Horace R T Williams. The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridioides difficileinfection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines. Gut 2024; : gutjnl-2023-331550 doi: 10.1136/gutjnl-2023-331550
|
| 9 |
Bruno Bonaz. Unmet needs of drugs for irritable bowel syndrome and inflammatory bowel diseases: interest of vagus nerve stimulation and hypnosis. Inflammopharmacology 2024; 32(2): 1005 doi: 10.1007/s10787-024-01446-7
|
| 10 |
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk. Factors underlying the Long-term Efficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome. Microbes and Infection 2024; : 105372 doi: 10.1016/j.micinf.2024.105372
|
| 11 |
Andrea Severino, Ege Tohumcu, Luca Tamai, Pasquale Dargenio, Serena Porcari, Debora Rondinella, Irene Venturini, Marcello Maida, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro. The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders. Best Practice & Research Clinical Gastroenterology 2024; : 101923 doi: 10.1016/j.bpg.2024.101923
|
| 12 |
Abbas Yadegar, Haggai Bar-Yoseph, Tanya Marie Monaghan, Sepideh Pakpour, Andrea Severino, Ed J. Kuijper, Wiep Klaas Smits, Elisabeth M. Terveer, Sukanya Neupane, Ali Nabavi-Rad, Javad Sadeghi, Giovanni Cammarota, Gianluca Ianiro, Estello Nap-Hill, Dickson Leung, Karen Wong, Dina Kao, Christopher Staley. Fecal microbiota transplantation: current challenges and future landscapes. Clinical Microbiology Reviews 2024; doi: 10.1128/cmr.00060-22
|
| 13 |
Monu Pandey, Jayanta Bhattacharyya. Gut Microbiota and Epigenetics in Colorectal Cancer: Implications for Carcinogenesis and Therapeutic Intervention. Epigenomics 2024; 16(6): 403 doi: 10.2217/epi-2023-0382
|